Regulations for the disposal of geneti-
INTRODUCTION
Genetically engineered animals have been developed for increased disease resistance, improved nutritional value, biopharm purposes (Kuroiwa et al., 2009 ), or as xenotransplant sources (van der Windt et al., 2009 ). We study genetically engineered goats that produce the spider silk proteins MaSp1 (M4; Xu and Lewis, 1990) and MaSp2 (M5; Hinman and Lewis, 1992) in their milk for investigational and commercial applications.
The Center for Veterinary Medicine works closely with researchers to block genetically engineered animals from entering the food supply before United States Food and Drug Administration (FDA) approval (Burns, 2008) . Consequently, all surplus investigational animals and their biological products (including milk) must be disposed of by incineration, burial, or composting (FDA, 2009) . With an outbreeding strategy, approximately 50% of the offspring born to transgenic (TG) animals will be nontransgenic (NTG). Because it is unknown whether DNA/cell transfer between mother and offspring or between littermates exists (Matsubara et al., 2009; Gammill and Nelson, 2010; Sunami et al., 2010; McConico et al., 2011; Boyon et al., 2011) , NTG littermates of TG animals and NTG mothers who give birth to TG offspring must be euthanized and disposed of as if they are TG. We add to the understanding of fetal-maternal and fetal-fetal transfer in goats by searching for transfer of transgenes encoding M4 and M5 from fetal TG offspring to their NTG dams and from a TG fetus to its littermates.
Additionally, transgenes utilizing β-casein promoters, such as M4 (US patent 7, 157, 615) , may be ectopically expressed (Maga et al., 1994; Farini and Whitelaw, 1995; Gutiérrez et al., 1996; Oh et al., 1999; Houdebine, 2000) . Understanding ectopic expression also has bearing on food safety and genetically engineered animal disposal practices. We attempted to detect expression of a M4 transgene outside of mammary tissue (lung, heart, liver, and brain) in a single TG necropsy animal using an M4-specific antibody.
MATERIALS AND METHODS
All animal procedures were approved by the University of Wyoming Animal Care and Use Committee.
Experimental Animals
All TG goats were Saanens obtained from Nexia Biotechnologies Ltd. (Quebec, Canada) who generated them using silk gene constructs for MaSp1 (M4) and MaSp2 (M5). The goats were imported from Canada with permission from the USDA and FDA. Nontransgenic goats were Saanens purchased locally. All goats were maintained in a double-fenced, secure facility at the University of Wyoming according to FDA regulations and USDA import regulations.
The goats used in this study are described in Table  1 . A total of 6 NTG dams (5 of which were used in the fetal-maternal transfer study) were bred to 1 of 4 TG bucks. One buck, Q4, possesses both M4 and a tandem double copy of M5, and is thus M4M55. From the 7 bred does, a total of 13 offspring were born (7 TG and 6 NTG). All chemicals were purchased from Sigma-Aldrich Company (St. Louis, MO) unless otherwise specified.
Purification of DNA from Blood
Blood (3 mL) was collected by venipuncture from dams (at multiple time points), bucks, and newborn offspring (within 3 d of birth) and was stored in blood collection tubes (Kendall monoject) containing 60 µL of 7.5% EDTA-K 3 (Animal Health Center, Laramie, WY). For the fetal-maternal transfer studies, NTG dams bred with TG bucks were bled midway through pregnancy (approximately 75 d postbreeding), 24 h before parturition, 24 h after parturition, and 30 d after parturition. For dilution experiments, blood was collected from a nonpregnant NTG dam and from a previously confirmed M5(+) TG dam.
Blood (200 µL) was diluted with 600 µL of ice-cold, nuclease-free deionized water. After incubation on ice (15 min), 200 µL of ice-cold buffer C1 (1.3 M sucrose, 20 mM magnesium chloride × 6 H 2 O, 0.35 M Tris, 4.2% Triton-X100) was added. Samples were mixed by inversion and incubated on ice (10 min). Nuclei were pelleted by centrifugation at 1,300 × g (15 min at 4°C), and the supernatant was removed by careful aspiration. A 700-µL volume of SNET (10 mM Tris, pH 8.0, 0.1 M EDTA, 0.5% SDS, 400 µg/mL of proteinase K) was added to each pellet to lyse nuclei. After overnight incubation at 50°C, samples were extracted with phenol:chloroform:isoamyl alcohol (25:24:1). The majority of the aqueous layer (500 µL) was removed by aspiration with a wide-bore pipette. The addition of an equal volume of isopropanol followed by 10 min incubation on ice precipitated the DNA, which was then pelleted by centrifugation (20 min, 18,000 × g at 25°C) in a tabletop centrifuge. The supernatant was gently aspirated and the pellet washed in 500 µL of ice-cold 70% ethanol and gently dried by vacuum evaporation (Speedvac, Thermo Scientific, Rockford, IL). Samples were resuspended in nuclease-free water (50 to 100 µL) and shaken at 65°C for 20 min to dissolve the DNA, which was quantified by optical density with a NanoVue (GE Healthcare, Piscataway, NJ). Care was taken to ensure the DNA was completely resuspended before Table 2 . Typical DNA yields were in the range of 3 to 12 µg.
Dilution of M5-Positive Blood with NTG Blood
Nontransgenic and M5(+) blood (200 µL) were added to 600 µL of nuclease-free water to generate NTG-diluted and M5-diluted, respectively. Dilutions of M5(+) blood were performed as described in Table 2 . Eight microliters of each dilution generated (Table 2, third column) were added to 792 µL of NTG-diluted to create the final dilution (Table 2, fourth column).
Conditions for PCR
Before PCR, DNA samples were diluted to 10 ng/ µL in nuclease-free water. The diluted DNA (10 µL, 100 ng) was added to 15 µL of GoTaq Colorless Master Mix (Promega Corporation, Madison, WI), 1 µL of each forward and reverse primer at 10 µM each, and 5% dimethyl sulfoxide. The specific primers used were hemoglobin (Hb)-1 and -2, M4-1 and -2, and M5-1 and -2 (Table 3 ). All M4 and M5 primers are directed to the coding region of the MaSp1 or MaSp2 transgenes, respectively. The Hb primers are based on the coding region of a caprine Hb gene. The PCR was carried out according to the following protocol: 94°C for 3 min, followed by 35 cycles of 94°C for 1 min, 62°C for 45 s, and 72°C for 30 s, followed by a final extension of 72°C for 10 min. The resulting products were electrophoresed on a 2% agarose gel in 0.5X TBE (Tris-borate-EDTA buffer) and photographed using a UVP BioSpectrum Multispectral imaging system (UVP, Upland, CA).
For the typing of offspring, fetal-maternal and fetalfetal transfer experiments, Hb-3 and -4, M4-3 and -4, and M5-1 and -2 primers were used. The PCR reactions were carried out using a similar protocol; however, only 30 cycles of 94°C for 1 min, 62°C for 45 s, and 72°C for 30 s were performed.
Offspring were named with the ID number of the dam followed by a lowercase letter in alphabetical order reflecting birth order. In the case of dam #9, 2 sets of twins (9a and b and 9c and d) were analyzed, with twins 9a and b being from an earlier gestation.
The following PCR controls were used: DNA isolated from blood of a NTG dam or buck, DNA isolated from a previously confirmed M4-expressing dam, and DNA isolated from a previously confirmed M5-expressing dam. For controls lacking template DNA, an equivalent amount of nuclease-free water was added to the PCR reaction in place of DNA.
Protein Extraction and Western Blot Analysis
To assess silk protein expression in various tissues, samples of heart, lung, liver, brain, and mammary tis- The volume of M5(+) blood specified in the first column was added to the volume of water indicated to generate a dilution listed in the third column. Eight microliters of these dilutions was added to 792 µL of NTG diluted blood to obtain the final dilution utilized in PCR assays depicted in Figure 1 . 
RESULTS

PCR on Goat DNA Is Sensitive to a 1:100,000 Dilution
To determine the sensitivity of our PCR assay, blood isolated from a M5(+) dam was diluted into blood from a NTG dam, and PCR was performed on the resultant mixed DNA in triplicate using M5-specific primers M5-1 and M5-2. A 252-bp M5 PCR-amplification product was observed to a 1:100,000 dilution ( Figure 1a) . Undiluted NTG DNA and M4(+) DNA did not amplify PCR products when M5 primers were used, and no PCR product was visualized in the absence of template. As expected, undiluted M4(+) DNA amplified a 168-bp M4-PCR product when the M4-specific primers M4-1 and M4-2 were used.
Primers Hb-1 and Hb-2 Control for DNA Quantity and Quality
To control for equal loading, PCR was performed on identical samples mentioned above using Hb primers Hb-1 and Hb-2. A 152-bp PCR product of similar staining intensity was observed in all goat DNA samples, indicating equivalent amounts of DNA were present in each lane (Figure 1b) .
Fetal-Maternal Transfer Is Not Observed Between TG Offspring and NTG Dams
Five NTG dams were bred with TG bucks previously determined to be TG with respect to M4, M5, or both M4 and M5 (M4M55; Table 1 ). Blood drawn from 3-dold offspring born to these NTG dams was analyzed to determine their TG status using the M4-3 and -4 and M5-1 and -2 primers. As a positive control, PCR was also performed using Hb-3 and -4 primers. Four of the 5 dams produced twins and the fifth (dam #12) gave birth to a singlet M5(+) buck (Table 1 and Figure 2b ). One set of NTG twin bucks was born to dam #9, and a set of TG twins was born to dam #30. Dams #19 and #31 each gave birth to twins of nonidentical TG status, a NTG buck and a M4(+) dam to dam #19 and a M4(+) buck and a NTG dam to dam #31. Of the 9 offspring born in the fetal-maternal study, 6 were male and 3 were female. Five of the 9 were TG (55.6%).
To search for fetal-maternal DNA transfer in our goats, blood samples were taken from dams during pregnancy, at parturition, and postpartum. The DNA isolated from blood was analyzed for the presence of M4 or M5 PCR-amplification products using the M4-3 and -4 and M5-1 and -2 primers, respectively. Hemoglobin primers Hb-3 and −4 were used for control reactions. Polymerase chain reaction amplicons for M4 and M5 genes (274 and 252 bp long, respectively) were not observed in any NTG dam tested, indicating fetalmaternal DNA transfer was undetectable at the time points assessed. The 401-bp Hb amplification product was detected in all samples (Figure 2a ) indicating sufficient template DNA was provided and that the DNA was of PCR-quality. A blood sample for dam #12 was not obtained 24 h before parturition as this dam gave birth prematurely.
The TG status of each buck used in breeding (Table 1) was confirmed by PCR analysis using identical primer sets and is visualized in Figure 2c . Buck #14 is M4(+), #13 and #23 are M5(+), and Q4 is M4M55(+).
Control reactions used identical PCR primer sets on DNA isolated from previously determined NTG, M4(+), and M5(+) goats. Hemoglobin and M4 PCRamplification products were observed in PCR reactions of a M4(+) dam (Figure 2d ). Likewise, Hb and M5 PCR-amplification products were generated from a DNA sample of a M5(+) dam. As expected, M4 and M5 PCR-amplification products were not observed in PCR reactions from a NTG dam and buck, and PCR reactions lacking template DNA did not have any observable PCR-amplification products.
Fetal-Fetal Transfer Is Not Observed Between Twins In Utero
To determine if fetal-fetal DNA transfer in utero can be detected using our methodologies, DNA purified from blood taken from 3-d-old offspring born to NTG dams was analyzed by PCR using the Hb-3 and -4, M4-3 and -4, and M5-1 and -2 primer sets. Twins 2a (NTG-M) and 2b [M4(+)-F] were born to NTG dam #2 and M4(+)-buck #14 (Figure 3a) , and twins 9a (NTG-M) and 9b (M4(+)-M) were born to NTG dam #9 and M4(+)-buck #14 (Figure 3b ). The fact that both twins in each set have a different TG status suggests that detectable fetal-fetal transfer of these genes does not occur in utero in the goat.
Silk Protein Is Not Detected in Tissue Other than Mammary Glands
To assess silk protein expression in nonmammary tissues, samples were obtained from a TG dam at nec- ) demonstration of DNA quality and equal loading. The DNA isolated from a spider silk MaSp2 (M5) (+) dam was diluted 1:1,000, 1:10,000, 1:25,000, 1:50,000, 1:75,000, and 1:100,000 into DNA isolated from a nontransgenic (NTG) dam, and PCR was performed on the resultant mixed DNA in triplicate using M5-specific primers. A 252-bp M5 PCR-amplification product was observed to a 1:100,000 dilution (a). Undiluted NTG DNA and spider silk MaSp1 (M4) (+)-DNA did not amplify PCR products when M5-specific primers were used, and no PCR product was visualized in the absence of template. Undiluted M4 (+)-DNA amplified a 168-bp M4 PCR-amplification product when M4-specific primers were used. To control for equal loading, PCR was performed on identical samples using hemoglobin (Hb)-specific primers (b). A 152-bp Hb PCR-amplification product of similar staining intensity was observed in all goat DNA samples, indicating equivalent amounts of DNA were present in each lane. L: 2-log ladder (New England Biolabs, Ipswich, MA). . The DNA isolated from blood was analyzed for the presence of MaSp1 (M4) and MaSp2 (M5) PCR-amplification products. Additionally, PCR using primers that amplify hemoglobin (Hb) was used for control reactions. A blood sample for dam number twelve 24 h before parturition was not taken because this dam delivered prematurely. All offspring from each dam were tested (b) and compared with the buck used in breeding using identical primer sets (c). Dam #9 had NTG twins (9c and 9d) but the previous year had twin transgenic kids (9a and 9b), so both the dam and new kids were tested to ensure no long-term fetal-maternal transfer had occurred. Control reactions (d) used identical PCR primer sets on DNA isolated from previously determined NTG, M4(+), and M5(+) goats. Hb, M4, and M5 throughout this figure represent duplicate PCR reactions (using a Hb, M4, or M5 primer set) electrophoresed on a 2% agarose gel, stained with ethidium bromide, and photographed using a UVP BioSpectrum Multispectral imaging system (UVP, Upland, CA). ID = identification number assigned to a specific goat; F = female; M = male.
ropsy. Protein isolated from heart, lung, liver, brain, and mammary tissue was subjected to SDS-PAGE and Western blot analysis using an M4-specific antibody. As observed in Figure 4 , M4 was detected only in the mammary gland tissue sample because the dam was lactating at the time of her death. High molecular weight material in the smear is suggestive of aggregation, which is common for the M4 protein, whereas proteins smaller than the 56.3-kD M4-milk control resulted from degradation, which has also been observed with M4-containing milk from multiple dams.
DISCUSSION
It is well documented that fetal cells and DNA cross the placental barrier during pregnancy in various mammals, including mice, cattle, and humans. Microchimerisms have been indicated by both XY fluorescent in situ hybridization (Hamada et al., 1993; O'Donoghue et al., 2003 O'Donoghue et al., , 2004 and PCR analysis (Hamada et al., 1993; Bianchi et al., 1997; Invernizzi et al., 2002) . The reported frequency of fetal cells in maternal blood ranges from 1 in 10,000 (Hamada et al., 1993) to 1 in 10,000,000 (Bianchi et al., 1997) in humans. It has been suggested that fetal-maternal transfer occurs in perhaps all human pregnancies (O'Donoghue et al., 2004) , and these cells have been reported to persist for decades (Bianchi et al., 1996; Invernizzi et al., 2002) . Fetal-maternal transfer has also been reported in mice; however, the fetal cells are not retained as they are in humans, and they rarely persist for more than a few months postpartum (Dawe et al., 2007) .
In humans and rodents, fetal-maternal transfer is aided by their highly invasive hemochorial placenta (Enders and Welsh, 1993; Turin et al., 2007a) , which allows for direct contact of maternal blood and the fetal placental chorion (Georgiades et al., 2002) . In contrast, ruminants possess epitheliochorial placentas consisting of multiple layers separating the 2 vascular systems (Turin et al., 2007a; Chucri et al., 2010) . This complex barrier between the maternal and fetal circulatory systems prevents immune transfer in epitheliochorial placentas, whereas it is facilitated by direct contact between maternal blood and the chorionic surface in hemochorial placentas (Chucri et al., 2010) . Therefore, one would predict that given the noninvasive nature of implantation in ruminants (Carter and Mess, 2010) and the presence of multiple tissue layers separating the fetal and maternal vascular systems, fetal-maternal transfer would be much less common in ruminants than in other mammals. Nevertheless, microchimerisms have been reported in cattle, albeit to a lesser extent. Hiendleder et al. (2003) detected mitrochondrial DNA (mtDNA) from recipient heifers implanted with embryos of differing maternal lineages in the circulation of 2 fetuses. The amount of maternal mtDNA in the fetal blood ranged between 2 and 5% with the greatest concentrations detected in blood compared with various tissues including the skin, lung, heart, rumen, spleen, and kidney (0.5 to 0.7%; Hiendleder et al., 2003) . Turin et al. (2007a,b) tested blood collected from mated heifers carrying male calves at various time points during gestation and postcalving for the presence of Y chromosomal and transgene sequences. The Figure 3 . Fetal-fetal transfer is not observed between goat twins in utero. Twins 2a and 2b were born to nontransgenic (NTG) dam #2 and MaSp1 (M4)(+) buck #14 (a). Twins 9a and 9b were born to NTG dam #9 and M4(+) buck #14 (b). Blood samples were taken from each twin within 3 d of birth. The DNA isolated from blood was analyzed for the presence of MaSp1 (M4) and MaSp2 (M5) PCRamplification products. Additionally, PCR using primers that amplify hemoglobin (Hb) was used for control reactions. No PCR-amplification products for spider silk protein genes were observed in either NTG twin (offspring 2a and 9a). The fact that both twins in each set are not of identical transgenic status indicates that fetal-fetal transfer did not occur in utero. Hb, M4, and M5 throughout this figure represent duplicate PCR reactions (using either a Hb, M4, or M5 primer set) electrophoresed on a 2% agarose gel, stained with ethidium bromide, and photographed using a UVP BioSpectrum Multispectral imaging system (UVP, Upland, CA). M = male; F = female. presence of Y chromosome PCR amplification products was detected at all time points tested. The greatest percentage of heifers with Y chromosomal DNA in their bloodstream was detected at calving (73%), whereas the largest percentage possessing transgene DNA was observed 4 mo postcalving (50%; Turin et al., 2007a,b) . Transgene sequences were also detected in the heart, lung, and lymph nodes of NTG heifers slaughtered 30 mo postcalving (Turin et al., 2007b) .
Although fetal-maternal transfer has been observed in the bovine, to our knowledge, caprine fetal-maternal transfer has not been reported. In fact, evidence suggests that it does not occur. Caprine embryos expressing green fluorescent protein (GFP) were generated by somatic cell nuclear transfer of adult goat fibroblast cells infected with a recombinant replication-deficient lentivirus carrying a GFP construct (Golding et al., 2006) . When the only obtained fetus was taken at d 81 and compared with that of an equivalent NTG fetus, all tissues derived from the TG fetus expressed GFP. After cross-sectional analysis, GFP expression was observed in fetal components of placentomes; however, the maternal tissue remained GFP-negative, suggesting that fetal-maternal transfer may not occur in caprines.
Due to the occurrence of microchimerisms in humans, as well as other mammals, concerns of fetal-maternal transfer between TG offspring and NTG parents and between TG and NTG twins in utero have forced researchers to take a conservative approach to the disposal of animals in research settings. Our studies corroborate those of Golding et al. (2006) and give further evidence that fetal-maternal transfer is not observed in goats.
We have utilized PCR to detect spider silk protein transgenes spiked into blood obtained from NTG dams. Aliquots of M5(+) blood, when diluted 1:100,000 into NTG blood, are detectable in our assay. This translates to a sensitivity of 0.40 ng/mL for the silk transgene sequences in our assay. This is greater than the amount of fetal-maternal microchimerism reported in the bovine. The average blood concentrations observed for a Y chromosome-specific gene (Y-S4) in the bovine was 0.04 ng/mL, and that for a CSN2/3 transgene sequence was 0.24 ng/mL (Turin et al., 2007a) . However, assuming an average of 9,000,000 white blood cells per milliliter in the adult goat (Smith and Sherman, 2009 ), our PCR assays are sensitive down to 90 cells per milliliter based on the 1:100,000 dilution. We are, therefore, able to detect as few as 90 TG cells in 1 mL of a NTG goat blood sample.
Using this PCR methodology, blood isolated from NTG dams carrying TG fetuses was examined for the presence of M4 and M5 PCR amplification products at various time points during pregnancy and 30 d postparturition. The complete lack of these PCR products indicates TG fetal cells/DNA were not present at a detectable concentration in the blood of the NTG dam, thereby suggesting that fetal-maternal transfer does not occur in the goat. Similarly, the absence of M4 and M5 PCR amplicons in all offspring tested suggest fetalfetal transfer also does not occur.
The authors acknowledge that these results do not preclude the existence of fetal-fetal or fetal-maternal michrochimerism due to the small number of available animals (n = 5 pregnancies for the fetal-maternal transfer study and n = 2 pregnancies for the fetal-fetal transfer study). However, the work presented does demonstrate that if fetal-fetal or fetal-maternal transfer does exist, it does so at very small amounts or infrequently. Our results are significant as our experiments failed to detect fetal microchimerism in blood, the bodily fluid/organ shown to be the most concentrated source of microchimeric cells in the ruminant (Hiendleder et al., 2003) . Testing blood taken at parturition was the primary focus, where the majority of fetal microchimerisms were detected in cattle (Turin et al., 2007a,b) ; however, we included other time points surrounding parturition to increase our chances of detection.
The tissue specificity of M4 transgene expression was confirmed by Western blot analyses, which failed to detect ectopic M4 transgene expression in heart, lung, liver, and brain tissue. Silk expression was only detected in mammary tissue. This is expected because the expression of the M4 silk protein is regulated by the β-casein promoter, which is primarily induced in the mammary gland.
Ectopic expression of mammary-specific transgenes have been reported in numerous tissues including tear ducts, salivary glands, brain, and lung tissue (Maga et al., 1994; Farini and Whitelaw, 1995; Gutiérrez et al., 1996; Oh et al., 1999; Houdebine, 2000; Chrenek et al., 2007) . The authors acknowledge that tissues known to display ectopic expression of mammary-specific transgenes were not analyzed. Tissues available for this study were collected from a standard necropsy of a M4-TG dam that died of natural causes. At the time of necropsy, given the limited number of goats and their inherent value, a standard tissue panel was collected and stored. Tissues were not collected with this specific study in mind. These data are presented to build the existing knowledge base of ectopic expression and not as a definitive work on the subject. Further herd attrition will result in an extensive library of tissues tailored to ectopic expression of mammary-specific transgenes that will be used to extend this research.
In conclusion, our inability to detect fetal-maternal or fetal-fetal transfer with a high-sensitivity PCR assay, coupled with supporting data from Golding et al. (2006) , suggest that fetal-maternal and fetal-fetal transfers of DNA do not occur frequently in the goat and that ectopic expression of this mammary-specific transgene is not occurring in the tissues available for this study. 
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